Antifibrotic Effect of Pirfenidone on Orbital Fibroblasts of Patients with Thyroid-Associated Ophthalmopathy by Decreasing TIMP-1 and Collagen Levels
Open Access
- 1 June 2010
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Opthalmology & Visual Science
- Vol. 51 (6), 3061-3066
- https://doi.org/10.1167/iovs.09-4257
Abstract
Purpose.: The aim of this study was to determine the antifibrotic effects of pirfenidone in orbital fibroblasts of patients with thyroid-associated ophthalmopathy (TAO). Methods.: The effects of interleukin (IL)-1β and of fibroblast growth factor (FGF), platelet-derived growth factor (PDGF), and transforming growth factor (TGF)-β on the induction of tissue inhibitors of metalloproteinases (TIMP)-1 were assessed in orbital fibroblasts of TAO patients. TIMP-1 protein levels were measured by ELISA and Western blot analyses, and TIMP-1 activity was assessed by reverse zymography. The effect of pirfenidone on TIMP-1 induction in orbital fibroblasts was evaluated with the same methods using dexamethasone as a reference agent. A hydroxyproline assay was used to determine the effect of pirfenidone and dexamethasone on collagen production in orbital fibroblasts, and the tetrazolium-based MTT assay was used to assess pirfenidone cytotoxicity. Results.: IL-1β strongly and dose dependently increased the level of active TIMP-1 protein, whereas FGF, PDGF, and TGF-β did not significantly induce TIMP-1 protein. Pirfenidone was more effective than dexamethasone in inhibiting IL-1β–induced increases in TIMP-1, reducing TIMP-1 levels to less than those in untreated controls at a minimal concentration (5 mM). Moreover, pirfenidone effectively decreased hydroxyproline levels in orbital fibroblasts, whereas dexamethasone had no effect on hydroxyproline levels. Pirfenidone exhibited no toxicity in orbital fibroblasts at the concentrations used. Conclusions.: These results indicate that nontoxic concentrations of pirfenidone have significant antifibrotic effects on orbital fibroblasts from patients with TAO.Keywords
This publication has 32 references indexed in Scilit:
- Effects of Pirfenidone on Proliferation, Migration, and Collagen Contraction of Human Tenon’s Fibroblasts In VitroInvestigative Opthalmology & Visual Science, 2009
- Imatinib Mesylate and AMN107 Inhibit PDGF-Signaling in Orbital Fibroblasts: A Potential Treatment for Graves' OphthalmopathyInvestigative Opthalmology & Visual Science, 2009
- Orbital Fibroblasts from Patients with Thyroid-Associated Ophthalmopathy Overexpress CD40: CD154 Hyperinduces IL-6, IL-8, and MCP-1Investigative Opthalmology & Visual Science, 2009
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- Losartan Attenuates Bleomycin-Induced Pulmonary Fibrosis in RatsRespiration, 2006
- Thyroid‐associated ophthalmopathy: a practical guide to classification, natural history and managementInternal Medicine Journal, 2004
- Differential Effects of Pirfenidone on Acute Pulmonary Injury and Ensuing Fibrosis in the Hamster Model of Amiodarone-Induced Pulmonary ToxicityToxicological Sciences, 2003
- Pathogenesis of Graves' Ophthalmopathy--Current UnderstandingJournal of Clinical Endocrinology & Metabolism, 2001
- Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse modelHepatology, 2000
- Prolyl 4-hydroxylase and its role in collagen synthesisJournal of Hepatology, 1991